Select Publications
Journal articles
2024, 'Rapid triage and transition to telehealth for heart transplant patients in the COVID-19 pandemic setting', Journal of Telemedicine and Telecare, 30, pp. 1481 - 1486, http://dx.doi.org/10.1177/1357633X231151714
,2024, 'Cardiac Magnetic Resonance Imaging for the early diagnosis of AL cardiomyopathy: A case series PB128 (#445)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b4
,2024, 'Cardiac transplantation for transthyretin amyloidosis (ATTR): A single centre experience PB152 (#446)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f5b7
,2024, 'Diagnosing Transthyretin Amyloidosis: A single centre experience with histopathological diagnosis PB91 (#553)', , http://dx.doi.org/10.26226/m.65f9bf8be6f73964e1d4f944
,2024, 'The prevalence of frailty and association with disease severity in transthyretin amyloid cardiomyopathy PC40 (#265)', , http://dx.doi.org/10.26226/m.65f9bf8ae6f73964e1d4f00f
,2024, '2024 Australia–New Zealand Expert Consensus Statement on Cardiac Amyloidosis', Heart Lung and Circulation, 33, pp. 420 - 442, http://dx.doi.org/10.1016/j.hlc.2023.11.027
,2024, 'Understanding Tricuspid Regurgitation Post Cardiac Transplantation; Why "Anatomical" and "Functional" Just Won't Cut It', Transplantation, 108, pp. 662 - 668, http://dx.doi.org/10.1097/TP.0000000000004740
,2024, 'AI FOR THE DETECTION OF CARDIAC AMYLOIDOSIS: INSIGHTS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS', Journal of the American College of Cardiology, 83, pp. 400 - 400, http://dx.doi.org/10.1016/s0735-1097(24)02390-8
,2024, 'AI for the Detection of Cardiac Amyloidosis: Insights From a Systematic Review and Meta-Analysis', Heart, Lung and Circulation, 33, pp. S160 - S161, http://dx.doi.org/10.1016/j.hlc.2024.06.082
,2024, 'Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation', JHLT Open, 5, pp. 100088 - 100088, http://dx.doi.org/10.1016/j.jhlto.2024.100088
,2024, 'Frailty Prevalence and Characteristics in a Transthyretin Amyloid Cardiomyopathy Cohort', Heart, Lung and Circulation, 33, pp. S131 - S131, http://dx.doi.org/10.1016/j.hlc.2024.06.023
,2024, 'Gender Trends of Left Ventricular Assist Device Insertion in Australia', The Journal of Heart and Lung Transplantation, 43, pp. S385 - S385, http://dx.doi.org/10.1016/j.healun.2024.02.1252
,2024, 'Gender Trends of Left Ventricular Assist Device Insertion in Australia', Heart, Lung and Circulation, 33, pp. S263 - S263, http://dx.doi.org/10.1016/j.hlc.2024.06.293
,2024, 'Increasing Recognition of Causes of HFpEF in Australia Over Time', The Journal of Heart and Lung Transplantation, 43, pp. S505 - S505, http://dx.doi.org/10.1016/j.healun.2024.02.706
,2024, 'Increasing Recognition of Causes of HFpEF in Australia Over Time', Heart, Lung and Circulation, 33, pp. S273 - S273, http://dx.doi.org/10.1016/j.hlc.2024.06.314
,2024, 'Investigating the Role of Genes and the Environment in Heart Failure With Preserved Ejection Fraction', Heart, Lung and Circulation, 33, pp. S129 - S130, http://dx.doi.org/10.1016/j.hlc.2024.06.019
,2024, 'OPTIMAL MODELLING FOR RIGHT VENTRICULAR AFTERLOAD ASSESSMENT IN PULMONARY HYPERTENSION', Journal of the American College of Cardiology, 83, pp. 2087 - 2087, http://dx.doi.org/10.1016/s0735-1097(24)04077-4
,2024, 'Rare Genetic Variants in Heart Failure with Preserved Ejection Fraction (HFpEF)', Heart, Lung and Circulation, 33, pp. S104 - S105, http://dx.doi.org/10.1016/j.hlc.2024.04.185
,2024, 'Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S148 - S149, http://dx.doi.org/10.1016/j.healun.2024.02.302
,2024, 'The Role of Cardiac Magnetic Resonance Imaging for Cardiac Staging of AL Amyloidosis', Heart, Lung and Circulation, 33, pp. S291 - S292, http://dx.doi.org/10.1016/j.hlc.2024.06.360
,2024, 'The Role of Specialist Nursing Education in a Hybrid Multidisciplinary Amyloidosis Clinic', Heart, Lung and Circulation, 33, pp. S330 - S330, http://dx.doi.org/10.1016/j.hlc.2024.06.446
,2023, 'How do mechanical circulatory support patients die? Autopsy findings for left-ventricular assist device/total artificial heart nonsurvivors', Journal of Heart and Lung Transplantation, 42, pp. 1753 - 1763, http://dx.doi.org/10.1016/j.healun.2023.07.001
,2023, 'Abstract 14249: Sex and Gene Based Differences in Age Related Penetrance of Dilated and Arrhythmogenic Cardiomyopathy', Circulation, 148, http://dx.doi.org/10.1161/circ.148.suppl_1.14249
,2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733
,2023, 'Emerging Roles of Artificial Intelligence (AI) in Cardiology: Benefits and Barriers in a ‘Brave New World’', Heart Lung and Circulation, 32, pp. 883 - 888, http://dx.doi.org/10.1016/j.hlc.2023.07.005
,2023, 'Case series: A cautionary tale of screening methods to detect severe cardiac allograft vasculopathy.', Transplantation Reports, 8, http://dx.doi.org/10.1016/j.tpr.2023.100134
,2023, 'Pre-operative pulmonary artery pulsatility index does not predict mortality post-cardiac transplantation', ESC Heart Failure, 10, pp. 1980 - 1986, http://dx.doi.org/10.1002/ehf2.14226
,2023, 'Prognostic role of pulmonary impedance estimation to predict right ventricular dysfunction in pulmonary hypertension', ESC Heart Failure, 10, pp. 1811 - 1821, http://dx.doi.org/10.1002/ehf2.14180
,2023, 'Tricuspid Regurgitation After Heart Transplantation: The Cause or the Result of Graft Dysfunction?', Transplantation, 107, pp. 1390 - 1397, http://dx.doi.org/10.1097/TP.0000000000004511
,2023, 'Acute Myocarditis and Pericarditis After mRNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart Lung and Circulation, 32, pp. 467 - 479, http://dx.doi.org/10.1016/j.hlc.2023.01.002
,2023, 'Characteristic changes to pulsatile and steady-state load according to pulmonary hypertension classification', Physiological Reports, 11, http://dx.doi.org/10.14814/phy2.15662
,2023, 'Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): Protocol for a randomised controlled trial', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-069641
,2023, 'Heart Transplantation from DCD Donors in Australia: Lessons Learned from the First 74 Cases', Transplantation, 107, pp. 361 - 371, http://dx.doi.org/10.1097/TP.0000000000004294
,2023, 'Is the left atrium the key in the amyloid imaging lock?', European Heart Journal Cardiovascular Imaging, 24, pp. E36, http://dx.doi.org/10.1093/ehjci/jeac223
,2023, 'Blood-Pressure-Monitoring Smartphone Applications: Ushering in a New Era of Wearable Cardiac Devices? Comment on Vischer et al. Comparability of a Blood-Pressure-Monitoring Smartphone Application with Conventional Measurements—A Pilot Study. Diagnostics 2022, 12, 749', Diagnostics, 13, http://dx.doi.org/10.3390/diagnostics13020290
,2023, 'Management of the arrhythmic manifestations of cardiac sarcoidosis', Frontiers in Cardiovascular Medicine, 10, pp. 1104947, http://dx.doi.org/10.3389/fcvm.2023.1104947
,2023, 'The role of frailty in advanced HF and cardiac transplantation', Frontiers in Cardiovascular Medicine, 10, http://dx.doi.org/10.3389/fcvm.2023.1082371
,2023, 'Thirty-day and one-year outcomes following transcatheter mitral valve edge-to-edge repair versus transapical mitral valve replacement in patients with left ventricular dysfunction', AsiaIntervention, 9, pp. 78 - 86, http://dx.doi.org/10.4244/AIJ-D-22-00049
,2023, 'World Heart Federation Consensus on Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM)', Global Heart, 18, http://dx.doi.org/10.5334/GH.1262
,2023, '(462) 'Tri'Ing to Clip the Gap: Percutaneous Tricuspid Intervention in a Heart Transplant', The Journal of Heart and Lung Transplantation, 42, pp. S212 - S213, http://dx.doi.org/10.1016/j.healun.2023.02.477
,2023, '(548) Bridge to Transplant and Transplant Outcomes in Cardiac Amyloidosis: A Systematic Review', The Journal of Heart and Lung Transplantation, 42, pp. S248 - S248, http://dx.doi.org/10.1016/j.healun.2023.02.563
,2023, '(847) Turning Back The Clock; A Unique Case of Reversible Pulmonary Hypertension', The Journal of Heart and Lung Transplantation, 42, pp. S370 - S370, http://dx.doi.org/10.1016/j.healun.2023.02.860
,2023, 'Acute Myocarditis and Pericarditis After M-RNA COVID-19 Vaccinations—A Single-Centre Retrospective Analysis', Heart, Lung and Circulation, 32, pp. S265 - S265, http://dx.doi.org/10.1016/j.hlc.2023.06.334
,2023, 'Bridge to Transplant and Transplant Outcomes in Cardiac Amyloidosis: A Systematic Review', Heart, Lung and Circulation, 32, pp. S271 - S271, http://dx.doi.org/10.1016/j.hlc.2023.06.350
,2023, 'Combined Plasmapheresis and Complement Inhibition in a Highly Allosensitised Cardiac Transplant Recipient', Heart, Lung and Circulation, 32, pp. S147 - S148, http://dx.doi.org/10.1016/j.hlc.2023.06.057
,2023, 'Discrepancies in the Clinical and Histopathological Diagnosis of Cardiomyopathy in a Heart Transplant Cohort', Heart, Lung and Circulation, 32, pp. S152 - S152, http://dx.doi.org/10.1016/j.hlc.2023.06.068
,2023, 'Intensive Tacrolimus Level Monitoring After Itraconazole Prophylaxis Cessation Reduces Acute Cellular Rejection Following Heart Transplant', Heart, Lung and Circulation, 32, pp. S164 - S164, http://dx.doi.org/10.1016/j.hlc.2023.06.095
,2023, 'Routine Donor-Specific Antibody Monitoring in Heart Transplant Recipients: Is There a Role?', Heart, Lung and Circulation, 32, pp. S176 - S176, http://dx.doi.org/10.1016/j.hlc.2023.06.122
,2023, 'Transthyretin Amyloidosis in Australia and New Zealand: The Cardiac Subcommittee of Australian Amyloidosis Network “Snap Shot” for 2022', Heart, Lung and Circulation, 32, pp. S181 - S182, http://dx.doi.org/10.1016/j.hlc.2023.06.135
,2022, 'Don't Miss the Boat! Determining Optimal Time of Referral for Cardiac Transplantation', Heart Lung and Circulation, 31, pp. 1561 - 1562, http://dx.doi.org/10.1016/j.hlc.2022.11.002
,